Literature DB >> 22669444

Wound dehiscence and stump infection after lower limb amputation: risk factors and association with antibiotic use.

Nathalie Dunkel1, Wilson Belaieff, Mathieu Assal, Valentina Corni, Şaziye Karaca, Alain Lacraz, Ilker Uçkay.   

Abstract

BACKGROUND: Optimal duration of antibiotic prophylaxis following major lower limb amputation in preventing adverse stump outcomes is controversial.
OBJECTIVE: We assess the epidemiology and risk factors of wound dehiscence and stump infection after mid-thigh to transmetatarsal amputations with regard to antibiotic administration.
METHODS: Our retrospective observational study at the Geneva University Hospital (January 1995-June 2010) includes a total of 289 amputations in 270 adult patients (199 males; median age 70 years).
RESULTS: Wound dehiscence and/or stump infection occurred in 47 (16.3%) and 63 (21.8%) patients with a median delay of 24 and 14 days, respectively. No clinical variable was significantly associated with stump infection. Diabetes and older age (>80 years) were associated with dehiscence. Importantly, transcutaneous tissue oxygen tension (TcPO2) and duration of antibiotic administration showed no association with either outcome.
CONCLUSION: The duration of antibiotic administration before or after surgery does not change the epidemiology of stump complications.

Entities:  

Mesh:

Year:  2012        PMID: 22669444     DOI: 10.1007/s00776-012-0245-5

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  9 in total

1.  An antibiotic stewardship program in a surgical ICU of a resource-limited country: financial impact with improved clinical outcomes.

Authors:  Kashif Hussain; Muhammad Faisal Khan; Gul Ambreen; Syed Shamim Raza; Seema Irfan; Kiren Habib; Hasnain Zafar
Journal:  J Pharm Policy Pract       Date:  2020-10-06

2.  Amputation stump perfusion is predictive of post-operative necrotic eschar formation.

Authors:  Gayan S De Silva; Khalid Saffaf; Luis A Sanchez; Mohamed A Zayed
Journal:  Am J Surg       Date:  2018-05-19       Impact factor: 2.565

3.  Stopping antibiotics after surgical amputation in diabetic foot and ankle infections-A daily practice cohort.

Authors:  Anne Rossel; Dan Lebowitz; Karim Gariani; Mohamed Abbas; Benjamin Kressmann; Mathieu Assal; Philippe Tscholl; Dimitrios Stafylakis; Ilker Uçkay
Journal:  Endocrinol Diabetes Metab       Date:  2019-02-06

4.  Changing perioperative prophylaxis during antibiotic therapy and iterative debridement for orthopedic infections?

Authors:  Lydia Wuarin; Mohamed Abbas; Stephan Harbarth; Felix Waibel; Dominique Holy; Jan Burkhard; Ilker Uçkay
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

5.  Clinical Evaluation of a Synthetic Hybrid-Scale Matrix in the Treatment of Lower Extremity Surgical Wounds.

Authors:  Daniel Tucker
Journal:  Cureus       Date:  2022-07-29

6.  The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies.

Authors:  Waseem Abu-Ashour; Laurie Twells; James Valcour; Amy Randell; Jennifer Donnan; Patricia Howse; John-Michael Gamble
Journal:  BMJ Open Diabetes Res Care       Date:  2017-05-27

7.  Should antibiotic prophylaxis before orthopedic implant surgery depend on the duration of pre-surgical hospital stay?

Authors:  Marie Davat; Lydia Wuarin; Dimitrios Stafylakis; Mohamed Abbas; Stephan Harbarth; Didier Hannouche; Ilker Uçkay
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-08       Impact factor: 4.887

Review 8.  Antimicrobial Prophylaxis for the Prevention of Surgical Site Infections in Orthopaedic Oncology - A Narrative Review of Current Concepts.

Authors:  Daniel Müller; Dominik Kaiser; Kati Sairanen; Thorsten Studhalter; İlker Uçkay
Journal:  J Bone Jt Infect       Date:  2019-10-15

9.  Applicability of Transcutaneous Oxygen Tension Measurement in the Assessment of Chronic Limb-Threatening Ischemia.

Authors:  Bernard Leenstra; Joep Wijnand; Bart Verhoeven; Olivier Koning; Martin Teraa; Marianne C Verhaar; Gert J de Borst
Journal:  Angiology       Date:  2019-08-06       Impact factor: 3.619

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.